UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Biological activity of tumor-treating fields in preclinical glioma models

Cell death & disease, 2017-04, Vol.8 (4), p.e2753-e2753

2017

Volltextzugriff (PDF)

NKG2D-Dependent Antitumor Effects of Chemotherapy and Radiotherapy against Glioblastoma

Clinical cancer research, 2018-02, Vol.24 (4), p.882-895

2018

Volltextzugriff (PDF)

Chemotherapy sensitization of glioblastoma by focused ultrasound-mediated delivery of therapeutic liposomes

Journal of controlled release, 2019-02, Vol.295, p.130-139

2019

Volltextzugriff (PDF)

Autocrine activation of the IFN signaling pathway may promote immune escape in glioblastoma

Neuro-oncology (Charlottesville, Va.), 2017-10, Vol.19 (10), p.1338-1349

2017

Volltextzugriff (PDF)

Differential roles of type I interferon signaling in tumor versus host cells in experimental glioma models

Translational oncology, 2023-02, Vol.28, p.101607, Article 101607

2023

Volltextzugriff (PDF)

Distinct molecular mechanisms of acquired resistance to temozolomide in glioblastoma cells

Journal of neurochemistry, 2012-07, Vol.122 (2), p.444-455

2012

Volltextzugriff (PDF)

HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy

Journal for immunotherapy of cancer, 2021-04, Vol.9 (4), p.e002071

2021

Volltextzugriff (PDF)

CD95 gene deletion may reduce clonogenic growth and invasiveness of human glioblastoma cells in a CD95 ligand-independent manner

Cell death discovery, 2022-07, Vol.8 (1), p.341-341, Article 341

2022

Volltextzugriff (PDF)

The natural HLA ligandome of glioblastoma stem-like cells: antigen discovery for T cell-based immunotherapy

Acta neuropathologica, 2018-06, Vol.135 (6), p.923-938

2018

Volltextzugriff (PDF)

Immunological and tumor-intrinsic mechanisms mediate the synergistic growth suppression of experimental glioblastoma by radiotherapy and MET inhibition

Acta neuropathologica communications, 2023-03, Vol.11 (1), p.41-41, Article 41

2023

Volltextzugriff (PDF)

ATPS-73BIOLOGICAL ACTIVITY OF TUMOR-TREATING FIELDS (TTFIELDS) IN GLIOMA MODELS IN A PRECLINICAL SETTING

Neuro-oncology (Charlottesville, Va.), 2015-11, Vol.17 (suppl 5), p.v34.3-v34

2015

Volltextzugriff (PDF)

Negative allosteric modulators of metabotropic glutamate receptor 3 target the stem-like phenotype of glioblastoma

Molecular therapy. Oncolytics, 2021-03, Vol.20, p.166-174

2021

Volltextzugriff (PDF)

CRISPR/Cas9-mediated abrogation of CD95L/CD95 signaling-induced glioma cell growth and immunosuppression increases survival in murine glioma models

Journal of neuro-oncology, 2022-11, Vol.160 (2), p.299-310

2022

Volltextzugriff (PDF)

Immunocytokines are a promising immunotherapeutic approach against glioblastoma

Science translational medicine, 2020-10, Vol.12 (564)

2020

Volltextzugriff (PDF)

CSIG-17. IMMUNE MODULATORY ROLE OF TYPE I INTERFERON IN SYNGENEIC MOUSE GLIOMA MODELS

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (Supplement_6), p.vi36-vi37

2021

Volltextzugriff (PDF)

Therapeutic Targeting of TGFβ Ligands in Glioblastoma Using Novel Antisense Oligonucleotides Reduces the Growth of Experimental Gliomas

Clinical cancer research, 2019-12, Vol.25 (23), p.7189-7201

2019

Volltextzugriff (PDF)

IMMU-13. COMBINED MODULATION OF THE TGF-Β PATHWAY AND GITR IMMUNE CHECKPOINT SIGNALING PROMOTES ANTI-TUMOR IMMUNITY IN SYNGENEIC GLIOMA MODELS

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (Supplement_6), p.vi94-vi94

2021

Volltextzugriff (PDF)

EXTH-53. VEGFR2-SPECIFIC CAR-T CELLS SHOW IMPROVED TUMOR INFILTRATION IN SYNGENEIC MOUSE GLIOMA MODELS

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v236-v236

2023

Volltextzugriff (PDF)

IMMU-53. IMPACT OF TUMOR-TREATING FIELDS (TTFIELDS) ON THE IMMUNOGENICITY OF GLIOMA CELLS

Neuro-oncology (Charlottesville, Va.), 2018-11, Vol.20 (suppl_6), p.vi133-vi133

2018

Volltextzugriff (PDF)

Transcriptional control of O 6 -methylguanine DNA methyltransferase expression and temozolomide resistance in glioblastoma

Journal of neurochemistry, 2018-03, Vol.144 (6), p.780-790

2018

Volltextzugriff (PDF)

EXTH-45. TARGETING GLIOBLASTOMA BY NOVEL INTEGRIN-SPECIFIC CAR T CELLS

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii219-vii219

2022

Volltextzugriff (PDF)

IMMU-27. SIMULTANEOUS TARGETING OF THE PD-L1 AND THE TGF-Β PATHWAYS WITH BINTRAFUSP ALFA IN EXPERIMENTAL GLIOMAS

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii137-vii137

2022

Volltextzugriff (PDF)

Association of peripheral blood CD4+ T-cell depletion under temozolomide with inferior survival of patients with IDH wildtype glioblastoma

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.2548-2548

2020

Volltextzugriff (PDF)

EXTH-21. MECHANISMS OF SYNERGISTIC GROWTH SUPPRESSION BY RADIOTHERAPY AND C-MET INHIBITION IN EXPERIMENTAL GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (Supplement_6), p.vi167-vi168

2021

Volltextzugriff (PDF)

EXTH-37. TARGETING THE IDH1R132H MUTATION IN GLIOMAS BY CRISPR-CAS PRECISION BASE EDITING

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii217-vii217

2022

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(50)

Sprache

Englisch
(50)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Biological activity of tumor-treating fields in preclinical glioma models

NKG2D-Dependent Antitumor Effects of Chemotherapy and Radiotherapy against Glioblastoma

Chemotherapy sensitization of glioblastoma by focused ultrasound-mediated delivery of therapeutic liposomes

Autocrine activation of the IFN signaling pathway may promote immune escape in glioblastoma

Differential roles of type I interferon signaling in tumor versus host cells in experimental glioma models

Distinct molecular mechanisms of acquired resistance to temozolomide in glioblastoma cells

HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy

CD95 gene deletion may reduce clonogenic growth and invasiveness of human glioblastoma cells in a CD95 ligand-independent manner

The natural HLA ligandome of glioblastoma stem-like cells: antigen discovery for T cell-based immunotherapy

Immunological and tumor-intrinsic mechanisms mediate the synergistic growth suppression of experimental glioblastoma by radiotherapy and MET inhibition

ATPS-73BIOLOGICAL ACTIVITY OF TUMOR-TREATING FIELDS (TTFIELDS) IN GLIOMA MODELS IN A PRECLINICAL SETTING

Negative allosteric modulators of metabotropic glutamate receptor 3 target the stem-like phenotype of glioblastoma

CRISPR/Cas9-mediated abrogation of CD95L/CD95 signaling-induced glioma cell growth and immunosuppression increases survival in murine glioma models

Immunocytokines are a promising immunotherapeutic approach against glioblastoma

CSIG-17. IMMUNE MODULATORY ROLE OF TYPE I INTERFERON IN SYNGENEIC MOUSE GLIOMA MODELS

Therapeutic Targeting of TGFβ Ligands in Glioblastoma Using Novel Antisense Oligonucleotides Reduces the Growth of Experimental Gliomas

IMMU-13. COMBINED MODULATION OF THE TGF-Β PATHWAY AND GITR IMMUNE CHECKPOINT SIGNALING PROMOTES ANTI-TUMOR IMMUNITY IN SYNGENEIC GLIOMA MODELS

EXTH-53. VEGFR2-SPECIFIC CAR-T CELLS SHOW IMPROVED TUMOR INFILTRATION IN SYNGENEIC MOUSE GLIOMA MODELS

IMMU-53. IMPACT OF TUMOR-TREATING FIELDS (TTFIELDS) ON THE IMMUNOGENICITY OF GLIOMA CELLS

Transcriptional control of O 6 -methylguanine DNA methyltransferase expression and temozolomide resistance in glioblastoma

EXTH-45. TARGETING GLIOBLASTOMA BY NOVEL INTEGRIN-SPECIFIC CAR T CELLS

IMMU-27. SIMULTANEOUS TARGETING OF THE PD-L1 AND THE TGF-Β PATHWAYS WITH BINTRAFUSP ALFA IN EXPERIMENTAL GLIOMAS

Association of peripheral blood CD4+ T-cell depletion under temozolomide with inferior survival of patients with IDH wildtype glioblastoma

EXTH-21. MECHANISMS OF SYNERGISTIC GROWTH SUPPRESSION BY RADIOTHERAPY AND C-MET INHIBITION IN EXPERIMENTAL GLIOBLASTOMA

EXTH-37. TARGETING THE IDH1R132H MUTATION IN GLIOMAS BY CRISPR-CAS PRECISION BASE EDITING

Suchergebnisse filtern